Investing.com -- Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) stock surged 10% after the company announced positive topline results from its Phase 2 trial evaluating bivamelagon, an investigational oral m ...

In the first half of 2025, Geely's BEV sales reached 510,803 units, a year-on-year growth of 173.09 percent. Its plug-in ...

NB Bancorp’s merger with Provident offers scale and EPS growth, despite risks. Find out why NBBK is the safer pick than PVBC ...

Despite external trade headwinds and tight domestic monetary conditions, Brazil’s finance ministry has upgraded its 2025 ...

Dinosaurs are alive and well at the box office as Universal’s “Jurassic World Rebirth” trampled competitors, grossing $147 ...

Welcome to the long-awaited return of what’s new on Netflix. This is your weekly recap of everything new added to Netflix over the past seven days, which saw 16 new movies and 13 new series added in ...

Network-as-a-service promises agility and efficiency, but its shared, dynamic nature demands a fundamentally new approach to ...

Meanwhile, data releases in the Eurozone were far from encouraging. The July Sentix Investor Confidence Index improved to 4.5 ...

From cosmic rays to CT scans, radiation surrounds us but not all exposure is dangerous. Here’s how to separate fact from fear ...

It's a case like Milli Vanilli's lip-syncing scandal of the 90s made for the artificial intelligence era. The Velvet Sundown ...

We've brought the Ford GT to the heart of Ferrari territory to the mountain back roads of Maranello, the very twisting routes ...